Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

4 treatments under study, led by Education

Research Leaders

7 sponsors active, led by Societe Francophone de Nutrition Enterale et Parenterale

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 1 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

100%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Phase 3 (1)

Trial Status

Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (1)

Research Network

Common Treatments

  • Education1
  • Oral Dietary Supplements 563 Kcald Respifor1
  • 160 Mgd Of Oral Testosterone Undecanoate In Men 80 Mgd In Women1
  • Exercises On An Ergometric Bicycle 3 To 5 Times A Week1

Active Sponsors

  • Societe Francophone de Nutrition Enterale et Parenterale1
  • University Hospital, Grenoble1
  • Ministry of Health, France1
  • Association AGIR à Dom,1
  • Association ANTADIR ,1

Top Investigators

Related Conditions

  • Chronic Respiratory Failure1

Activity Timeline